Tacrolimus
NDC 85972-101, Tacrolimus, capsule, from Stellon Biotech Inc..
- Product NDC
- 85972-101
- Status
- Listed
- Labeler
- Stellon Biotech Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213112
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85972-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TACROLIMUS.5 mg/1
Pharmacologic classes
Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85972-101-01 | 85972010101 | 100 CAPSULE in 1 BOTTLE (85972-101-01) |
| 85972-101-30 | 85972010130 | 30 CAPSULE in 1 BOTTLE (85972-101-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/6b89e8a4-9f11-42e3-8e79-fe617e7c461fNADAC price for package 85972010101
GET /v1/drugs/nadac/85972010101
Use it
Look up 85972-101 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85972-101 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85972-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.